Skip to main content
. 2019 Dec 9;19(2):1033–1041. doi: 10.3892/etm.2019.8306

Figure 2.

Figure 2.

Subgroup analyses for the association of serum adiponectin or resistin levels in patients with KD. Meta-analysis of (A) circulating resistin levels in KD group vs. HC group; (B) circulating resistin levels in KD group vs. DC group; (C) circulating adiponectin levels in CAL group vs. NCAL group; (D) circulating resistin levels in CAL group vs. NCAL group; and (E) circulating resistin levels in active vs. inactive disease group. Fixed, fixed-effects model; Random, random-effects model; KD, Kawasaki disease; NCAL, non-coronary artery lesions; HC, healthy control; DC, disease control; IV, inverse variance; SD, standard deviation; DF, degrees of freedom; CAL, coronary artery lesions.